Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 126 participants.

Also called NCT07073768

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 126 participants (planned count) (from the registry)
Sponsor
Khyber Medical College, Peshawar (from the registry)
Registry
  • NCT NCT07073768
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT07073768. Randomized; no masking; primary purpose treatment. Start 2025-07-01 (actual); primary completion 2026-12-26 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
Condition
Diabetes Mellitus Type 2
Condition
Glycemic Control for Diabetes Mellitus
Intervention (Drug)
Trelagliptin 100 mg
Intervention (Drug)
Sitagliptin 100mg OD
Lead sponsor
Khyber Medical College, Peshawar (class: other)

Record details

Record id
cardio:ct-nct07073768
Content hash
d20e4ad1e8e3c08c8a3ad72db43f8b5d54ba52af85d3984fe18c408b4f4882ab